China Medical GatewayLoading your healthcare gateway…

Arrhythmia & Atrial Fibrillation in China

Overview

Arrhythmias are disorders of the heart’s electrical system in which the heart may beat too fast, too slowly or irregularly. Atrial fibrillation (AF), the most common sustained arrhythmia, raises stroke risk five-fold when untreated but is highly manageable with modern rate control, anticoagulation and ablation strategies.

Chinese electrophysiology laboratories perform among the world’s largest volumes of AF ablation, giving patients access to deeply experienced operators and the newest energy platforms.

Symptoms & Signs

Palpitations — a fluttering, racing or pounding sensation in the chest

Irregular pulse noticed at rest or discovered on a routine checkup ECG

Dizziness, breathlessness and reduced exercise tolerance

Fatigue and unexplained decline in stamina, particularly in older patients

Silent AF with no symptoms at all — still carrying stroke risk and requiring management

Dangerous fast rhythms (ventricular tachycardia) causing fainting or cardiac arrest in structural heart disease

Diagnosis

Resting 12-lead ECG and 24-hour Holter monitoring

Extended event recorders and implantable loop recorders for infrequent episodes

Electrophysiology study mapping the arrhythmia circuit in detail

Echocardiography assessing structural heart disease and atrial size

CHA2DS2-VASc stroke-risk scoring to guide anticoagulation decisions

Sleep apnea and thyroid screening, since both commonly trigger AF

Treatment Options

Rate-control medication (beta-blockers, calcium-channel blockers) and antiarrhythmic drug therapy

Anticoagulation to prevent stroke, with novel oral anticoagulants as first-line therapy

Left atrial appendage closure for patients who cannot take long-term anticoagulation

Catheter ablation — radiofrequency or cryoballoon — isolating the pulmonary veins for paroxysmal and persistent AF

Pacemaker implantation for slow rhythms, including physiological (conduction-system) pacing

ICD defibrillators and CRT resynchronization therapy for heart-failure patients with dangerous rhythms

Advanced Technologies & Novel Drug

3D electroanatomic mapping systems (CARTO-class) enabling precise lesion placement

Cryoballoon and pulsed-field ablation (PFA) — a newer energy source with improved safety margins

Leadless pacemakers and MRI-compatible device platforms

Robotic magnetic navigation for complex arrhythmia substrates

Domestically developed ablation catheters and novel antiarrhythmic agents available at leading EP centers

Hospital & Specialist

Return to Home